Standard treatment of advanced-stage diffuse large B-cell lymphoma

被引：18

作者：

Coiffier, Bertrand

机构：

[1] Univ Lyon 1, F-69365 Lyon, France

[2] Hospices Civils Lyon, Lyon, France

来源：

SEMINARS IN HEMATOLOGY | 2006年 / 43卷 / 04期

关键词：

D O I：

10.1053/j.seminhematol.2006.07.004

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoma and is not localized in 70% of the cases. Even if the clinical picture, the morphologic aspect, and the prognostic parameters are different from one patient to another, the standard treatment is the same for all patients. Currently, treatment decision is based on the International Prognostic Index (IPI) and age of the patient. Outcome has been completely modified with the introduction of rituximab in combination with chemotherapy. A review of standard treatment and remaining questions is presented. © 2006 Elsevier Inc. All rights reserved.

引用

收藏

页码：213 / 220

页数：8

相关论文

共 37 条

[1]

Non-Hodgkin's lymphoma in patients 80 years of age or older [J].

Bairey, O ;

Benjamini, O ;

Blickstein, D ;

Elis, A ;

Ruchlemer, R .

ANNALS OF ONCOLOGY, 2006, 17 (06) :928-934

[2]

Primary CNS lymphoma [J].

Batchelor, T ;

Loeffler, JS .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (08) :1281-1288

[3]

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: A phase II study of the Southwest Oncology Group (SWOG 9349) [J].

Blayney, DW ;

LeBlanc, ML ;

Grogan, T ;

Gaynor, ER ;

Chapman, RA ;

Spiridonidis, CH ;

Taylor, SA ;

Bearman, SI ;

Miller, TP ;

Fisher, RI .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (13) :2466-2473

[4]

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas [J].

Cheson, BD ;

Horning, SJ ;

Coiffier, B ;

Shipp, MA ;

Fisher, RI ;

Connors, JM ;

Lister, TA ;

Vose, J ;

Grillo-López, A ;

Hagenbeek, A ;

Cabanillas, F ;

Klippensten, D ;

Hiddemann, W ;

Castellino, R ;

Harris, NL ;

Armitage, JO ;

Carter, W ;

Hoppe, R ;

Canellos, GP .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1244-1253

[5]

Increasing chemotherapy intensity in aggressive lymphomas: A renewal? [J].

Coiffier, B .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (13) :2457-2459

[6]

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].

Coiffier, B ;

Lepage, E ;

Brière, J ;

Herbrecht, R ;

Tilly, H ;

Bouabdallah, R ;

Morel, P ;

Van den Neste, E ;

Salles, G ;

Gaulard, P ;

Reyes, F ;

Gisselbrecht, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242

[7]

Coiffier B, 1998, BLOOD, V92, P1927

[8]

COIFFIER B, 2003, ASCO ED BOOK SPR, P606

[9]

Coiffier Bertrand, 2005, Curr Hematol Rep, V4, P7

[10]

Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy:: 9-year follow-up [J].

Czuczman, MS ;

Weaver, R ;

Alkuzweny, B ;

Berlfein, J ;

Grillo-López, AJ .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) :4711-4716

← 1 2 3 4 →